Global Dementia Drugs Market Insights and Forecast to 2028

Report ID: 1802439 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Dementia Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Dementia Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 MAO Inhibitors
        1.2.3 Cholinesterase Inhibitors
        1.2.4 Glutamate Inhibitors
    1.3 Market by Application
        1.3.1 Global Dementia Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Dementia Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Dementia Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Dementia Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Dementia Drugs Sales by Region
        2.4.1 Global Dementia Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Dementia Drugs by Region (2023-2028)
    2.5 Global Dementia Drugs Revenue by Region
        2.5.1 Global Dementia Drugs Revenue by Region (2017-2022)
        2.5.2 Global Dementia Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Dementia Drugs Sales by Manufacturers
        3.1.1 Global Top Dementia Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Dementia Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Dementia Drugs in 2021
    3.2 Global Dementia Drugs Revenue by Manufacturers
        3.2.1 Global Dementia Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Dementia Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Dementia Drugs Revenue in 2021
    3.3 Global Dementia Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Dementia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Dementia Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Dementia Drugs Sales by Type
        4.1.1 Global Dementia Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Dementia Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Dementia Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Dementia Drugs Revenue by Type
        4.2.1 Global Dementia Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Dementia Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Dementia Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Dementia Drugs Price by Type
        4.3.1 Global Dementia Drugs Price by Type (2017-2022)
        4.3.2 Global Dementia Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Dementia Drugs Sales by Application
        5.1.1 Global Dementia Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Dementia Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Dementia Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Dementia Drugs Revenue by Application
        5.2.1 Global Dementia Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Dementia Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Dementia Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Dementia Drugs Price by Application
        5.3.1 Global Dementia Drugs Price by Application (2017-2022)
        5.3.2 Global Dementia Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Dementia Drugs Market Size by Type
        6.1.1 North America Dementia Drugs Sales by Type (2017-2028)
        6.1.2 North America Dementia Drugs Revenue by Type (2017-2028)
    6.2 North America Dementia Drugs Market Size by Application
        6.2.1 North America Dementia Drugs Sales by Application (2017-2028)
        6.2.2 North America Dementia Drugs Revenue by Application (2017-2028)
    6.3 North America Dementia Drugs Market Size by Country
        6.3.1 North America Dementia Drugs Sales by Country (2017-2028)
        6.3.2 North America Dementia Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Dementia Drugs Market Size by Type
        7.1.1 Europe Dementia Drugs Sales by Type (2017-2028)
        7.1.2 Europe Dementia Drugs Revenue by Type (2017-2028)
    7.2 Europe Dementia Drugs Market Size by Application
        7.2.1 Europe Dementia Drugs Sales by Application (2017-2028)
        7.2.2 Europe Dementia Drugs Revenue by Application (2017-2028)
    7.3 Europe Dementia Drugs Market Size by Country
        7.3.1 Europe Dementia Drugs Sales by Country (2017-2028)
        7.3.2 Europe Dementia Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Dementia Drugs Market Size by Type
        8.1.1 Asia Pacific Dementia Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Dementia Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Dementia Drugs Market Size by Application
        8.2.1 Asia Pacific Dementia Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Dementia Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Dementia Drugs Market Size by Region
        8.3.1 Asia Pacific Dementia Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Dementia Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Dementia Drugs Market Size by Type
        9.1.1 Latin America Dementia Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Dementia Drugs Revenue by Type (2017-2028)
    9.2 Latin America Dementia Drugs Market Size by Application
        9.2.1 Latin America Dementia Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Dementia Drugs Revenue by Application (2017-2028)
    9.3 Latin America Dementia Drugs Market Size by Country
        9.3.1 Latin America Dementia Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Dementia Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Dementia Drugs Market Size by Type
        10.1.1 Middle East and Africa Dementia Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Dementia Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Dementia Drugs Market Size by Application
        10.2.1 Middle East and Africa Dementia Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Dementia Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Dementia Drugs Market Size by Country
        10.3.1 Middle East and Africa Dementia Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Dementia Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Eisai, Inc
        11.1.1 Eisai, Inc Corporation Information
        11.1.2 Eisai, Inc Overview
        11.1.3 Eisai, Inc Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Eisai, Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Eisai, Inc Recent Developments
    11.2 Janssen Pharmaceuticals, Inc
        11.2.1 Janssen Pharmaceuticals, Inc Corporation Information
        11.2.2 Janssen Pharmaceuticals, Inc Overview
        11.2.3 Janssen Pharmaceuticals, Inc Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Janssen Pharmaceuticals, Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Janssen Pharmaceuticals, Inc Recent Developments
    11.3 Biogen Pharmaceuticals
        11.3.1 Biogen Pharmaceuticals Corporation Information
        11.3.2 Biogen Pharmaceuticals Overview
        11.3.3 Biogen Pharmaceuticals Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Biogen Pharmaceuticals Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Biogen Pharmaceuticals Recent Developments
    11.4 Forest Laboratories, Inc
        11.4.1 Forest Laboratories, Inc Corporation Information
        11.4.2 Forest Laboratories, Inc Overview
        11.4.3 Forest Laboratories, Inc Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Forest Laboratories, Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Forest Laboratories, Inc Recent Developments
    11.5 Eli Lilly and Company
        11.5.1 Eli Lilly and Company Corporation Information
        11.5.2 Eli Lilly and Company Overview
        11.5.3 Eli Lilly and Company Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Eli Lilly and Company Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Eli Lilly and Company Recent Developments
    11.6 Novartis AG
        11.6.1 Novartis AG Corporation Information
        11.6.2 Novartis AG Overview
        11.6.3 Novartis AG Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Novartis AG Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Novartis AG Recent Developments
    11.7 Sanofi S.A
        11.7.1 Sanofi S.A Corporation Information
        11.7.2 Sanofi S.A Overview
        11.7.3 Sanofi S.A Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Sanofi S.A Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Sanofi S.A Recent Developments
    11.8 AstraZeneca GmbH
        11.8.1 AstraZeneca GmbH Corporation Information
        11.8.2 AstraZeneca GmbH Overview
        11.8.3 AstraZeneca GmbH Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 AstraZeneca GmbH Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 AstraZeneca GmbH Recent Developments
    11.9 F. Hoffmann-La Roche
        11.9.1 F. Hoffmann-La Roche Corporation Information
        11.9.2 F. Hoffmann-La Roche Overview
        11.9.3 F. Hoffmann-La Roche Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 F. Hoffmann-La Roche Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 F. Hoffmann-La Roche Recent Developments
    11.10 Merck & Co., Inc
        11.10.1 Merck & Co., Inc Corporation Information
        11.10.2 Merck & Co., Inc Overview
        11.10.3 Merck & Co., Inc Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Merck & Co., Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Merck & Co., Inc Recent Developments
    11.11 Valeant Pharmaceutical International
        11.11.1 Valeant Pharmaceutical International Corporation Information
        11.11.2 Valeant Pharmaceutical International Overview
        11.11.3 Valeant Pharmaceutical International Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Valeant Pharmaceutical International Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Valeant Pharmaceutical International Recent Developments
    11.12 Pfizer Inc
        11.12.1 Pfizer Inc Corporation Information
        11.12.2 Pfizer Inc Overview
        11.12.3 Pfizer Inc Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Pfizer Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Pfizer Inc Recent Developments
    11.13 Teva Pharmaceuticals Industries
        11.13.1 Teva Pharmaceuticals Industries Corporation Information
        11.13.2 Teva Pharmaceuticals Industries Overview
        11.13.3 Teva Pharmaceuticals Industries Dementia Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 Teva Pharmaceuticals Industries Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 Teva Pharmaceuticals Industries Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Dementia Drugs Industry Chain Analysis
    12.2 Dementia Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Dementia Drugs Production Mode & Process
    12.4 Dementia Drugs Sales and Marketing
        12.4.1 Dementia Drugs Sales Channels
        12.4.2 Dementia Drugs Distributors
    12.5 Dementia Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Dementia Drugs Industry Trends
    13.2 Dementia Drugs Market Drivers
    13.3 Dementia Drugs Market Challenges
    13.4 Dementia Drugs Market Restraints
14 Key Findings in The Global Dementia Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global Dementia Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of MAO Inhibitors
    Table 3. Major Manufacturers of Cholinesterase Inhibitors
    Table 4. Major Manufacturers of Glutamate Inhibitors
    Table 5. Global Dementia Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Dementia Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Dementia Drugs Sales by Region (2017-2022) & (K Units)
    Table 8. Global Dementia Drugs Sales Market Share by Region (2017-2022)
    Table 9. Global Dementia Drugs Sales by Region (2023-2028) & (K Units)
    Table 10. Global Dementia Drugs Sales Market Share by Region (2023-2028)
    Table 11. Global Dementia Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 12. Global Dementia Drugs Revenue Market Share by Region (2017-2022)
    Table 13. Global Dementia Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 14. Global Dementia Drugs Revenue Market Share by Region (2023-2028)
    Table 15. Global Dementia Drugs Sales by Manufacturers (2017-2022) & (K Units)
    Table 16. Global Dementia Drugs Sales Share by Manufacturers (2017-2022)
    Table 17. Global Dementia Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 18. Global Dementia Drugs Revenue Share by Manufacturers (2017-2022)
    Table 19. Dementia Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 20. Global Dementia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 21. Global Dementia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dementia Drugs as of 2021)
    Table 22. Dementia Drugs Manufacturing Base Distribution and Headquarters
    Table 23. Manufacturers Dementia Drugs Product Offered
    Table 24. Date of Manufacturers Enter into Dementia Drugs Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Dementia Drugs Sales by Type (2017-2022) & (K Units)
    Table 27. Global Dementia Drugs Sales by Type (2023-2028) & (K Units)
    Table 28. Global Dementia Drugs Sales Share by Type (2017-2022)
    Table 29. Global Dementia Drugs Sales Share by Type (2023-2028)
    Table 30. Global Dementia Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 31. Global Dementia Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 32. Global Dementia Drugs Revenue Share by Type (2017-2022)
    Table 33. Global Dementia Drugs Revenue Share by Type (2023-2028)
    Table 34. Dementia Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 35. Global Dementia Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 36. Global Dementia Drugs Sales by Application (2017-2022) & (K Units)
    Table 37. Global Dementia Drugs Sales by Application (2023-2028) & (K Units)
    Table 38. Global Dementia Drugs Sales Share by Application (2017-2022)
    Table 39. Global Dementia Drugs Sales Share by Application (2023-2028)
    Table 40. Global Dementia Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 41. Global Dementia Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 42. Global Dementia Drugs Revenue Share by Application (2017-2022)
    Table 43. Global Dementia Drugs Revenue Share by Application (2023-2028)
    Table 44. Dementia Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 45. Global Dementia Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 46. North America Dementia Drugs Sales by Type (2017-2022) & (K Units)
    Table 47. North America Dementia Drugs Sales by Type (2023-2028) & (K Units)
    Table 48. North America Dementia Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 49. North America Dementia Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 50. North America Dementia Drugs Sales by Application (2017-2022) & (K Units)
    Table 51. North America Dementia Drugs Sales by Application (2023-2028) & (K Units)
    Table 52. North America Dementia Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 53. North America Dementia Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 54. North America Dementia Drugs Sales by Country (2017-2022) & (K Units)
    Table 55. North America Dementia Drugs Sales by Country (2023-2028) & (K Units)
    Table 56. North America Dementia Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 57. North America Dementia Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 58. Europe Dementia Drugs Sales by Type (2017-2022) & (K Units)
    Table 59. Europe Dementia Drugs Sales by Type (2023-2028) & (K Units)
    Table 60. Europe Dementia Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 61. Europe Dementia Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 62. Europe Dementia Drugs Sales by Application (2017-2022) & (K Units)
    Table 63. Europe Dementia Drugs Sales by Application (2023-2028) & (K Units)
    Table 64. Europe Dementia Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 65. Europe Dementia Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 66. Europe Dementia Drugs Sales by Country (2017-2022) & (K Units)
    Table 67. Europe Dementia Drugs Sales by Country (2023-2028) & (K Units)
    Table 68. Europe Dementia Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 69. Europe Dementia Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 70. Asia Pacific Dementia Drugs Sales by Type (2017-2022) & (K Units)
    Table 71. Asia Pacific Dementia Drugs Sales by Type (2023-2028) & (K Units)
    Table 72. Asia Pacific Dementia Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 73. Asia Pacific Dementia Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 74. Asia Pacific Dementia Drugs Sales by Application (2017-2022) & (K Units)
    Table 75. Asia Pacific Dementia Drugs Sales by Application (2023-2028) & (K Units)
    Table 76. Asia Pacific Dementia Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 77. Asia Pacific Dementia Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 78. Asia Pacific Dementia Drugs Sales by Region (2017-2022) & (K Units)
    Table 79. Asia Pacific Dementia Drugs Sales by Region (2023-2028) & (K Units)
    Table 80. Asia Pacific Dementia Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 81. Asia Pacific Dementia Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 82. Latin America Dementia Drugs Sales by Type (2017-2022) & (K Units)
    Table 83. Latin America Dementia Drugs Sales by Type (2023-2028) & (K Units)
    Table 84. Latin America Dementia Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 85. Latin America Dementia Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 86. Latin America Dementia Drugs Sales by Application (2017-2022) & (K Units)
    Table 87. Latin America Dementia Drugs Sales by Application (2023-2028) & (K Units)
    Table 88. Latin America Dementia Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 89. Latin America Dementia Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 90. Latin America Dementia Drugs Sales by Country (2017-2022) & (K Units)
    Table 91. Latin America Dementia Drugs Sales by Country (2023-2028) & (K Units)
    Table 92. Latin America Dementia Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 93. Latin America Dementia Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 94. Middle East and Africa Dementia Drugs Sales by Type (2017-2022) & (K Units)
    Table 95. Middle East and Africa Dementia Drugs Sales by Type (2023-2028) & (K Units)
    Table 96. Middle East and Africa Dementia Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 97. Middle East and Africa Dementia Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 98. Middle East and Africa Dementia Drugs Sales by Application (2017-2022) & (K Units)
    Table 99. Middle East and Africa Dementia Drugs Sales by Application (2023-2028) & (K Units)
    Table 100. Middle East and Africa Dementia Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 101. Middle East and Africa Dementia Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 102. Middle East and Africa Dementia Drugs Sales by Country (2017-2022) & (K Units)
    Table 103. Middle East and Africa Dementia Drugs Sales by Country (2023-2028) & (K Units)
    Table 104. Middle East and Africa Dementia Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 105. Middle East and Africa Dementia Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 106. Eisai, Inc Corporation Information
    Table 107. Eisai, Inc Description and Major Businesses
    Table 108. Eisai, Inc Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 109. Eisai, Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 110. Eisai, Inc Recent Developments
    Table 111. Janssen Pharmaceuticals, Inc Corporation Information
    Table 112. Janssen Pharmaceuticals, Inc Description and Major Businesses
    Table 113. Janssen Pharmaceuticals, Inc Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 114. Janssen Pharmaceuticals, Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 115. Janssen Pharmaceuticals, Inc Recent Developments
    Table 116. Biogen Pharmaceuticals Corporation Information
    Table 117. Biogen Pharmaceuticals Description and Major Businesses
    Table 118. Biogen Pharmaceuticals Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 119. Biogen Pharmaceuticals Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 120. Biogen Pharmaceuticals Recent Developments
    Table 121. Forest Laboratories, Inc Corporation Information
    Table 122. Forest Laboratories, Inc Description and Major Businesses
    Table 123. Forest Laboratories, Inc Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 124. Forest Laboratories, Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 125. Forest Laboratories, Inc Recent Developments
    Table 126. Eli Lilly and Company Corporation Information
    Table 127. Eli Lilly and Company Description and Major Businesses
    Table 128. Eli Lilly and Company Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 129. Eli Lilly and Company Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 130. Eli Lilly and Company Recent Developments
    Table 131. Novartis AG Corporation Information
    Table 132. Novartis AG Description and Major Businesses
    Table 133. Novartis AG Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 134. Novartis AG Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 135. Novartis AG Recent Developments
    Table 136. Sanofi S.A Corporation Information
    Table 137. Sanofi S.A Description and Major Businesses
    Table 138. Sanofi S.A Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 139. Sanofi S.A Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 140. Sanofi S.A Recent Developments
    Table 141. AstraZeneca GmbH Corporation Information
    Table 142. AstraZeneca GmbH Description and Major Businesses
    Table 143. AstraZeneca GmbH Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 144. AstraZeneca GmbH Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 145. AstraZeneca GmbH Recent Developments
    Table 146. F. Hoffmann-La Roche Corporation Information
    Table 147. F. Hoffmann-La Roche Description and Major Businesses
    Table 148. F. Hoffmann-La Roche Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 149. F. Hoffmann-La Roche Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 150. F. Hoffmann-La Roche Recent Developments
    Table 151. Merck & Co., Inc Corporation Information
    Table 152. Merck & Co., Inc Description and Major Businesses
    Table 153. Merck & Co., Inc Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 154. Merck & Co., Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 155. Merck & Co., Inc Recent Developments
    Table 156. Valeant Pharmaceutical International Corporation Information
    Table 157. Valeant Pharmaceutical International Description and Major Businesses
    Table 158. Valeant Pharmaceutical International Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 159. Valeant Pharmaceutical International Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 160. Valeant Pharmaceutical International Recent Developments
    Table 161. Pfizer Inc Corporation Information
    Table 162. Pfizer Inc Description and Major Businesses
    Table 163. Pfizer Inc Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 164. Pfizer Inc Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 165. Pfizer Inc Recent Developments
    Table 166. Teva Pharmaceuticals Industries Corporation Information
    Table 167. Teva Pharmaceuticals Industries Description and Major Businesses
    Table 168. Teva Pharmaceuticals Industries Dementia Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 169. Teva Pharmaceuticals Industries Dementia Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 170. Teva Pharmaceuticals Industries Recent Developments
    Table 171. Key Raw Materials Lists
    Table 172. Raw Materials Key Suppliers Lists
    Table 173. Dementia Drugs Distributors List
    Table 174. Dementia Drugs Customers List
    Table 175. Dementia Drugs Market Trends
    Table 176. Dementia Drugs Market Drivers
    Table 177. Dementia Drugs Market Challenges
    Table 178. Dementia Drugs Market Restraints
    Table 179. Research Programs/Design for This Report
    Table 180. Key Data Information from Secondary Sources
    Table 181. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dementia Drugs Product Picture
    Figure 3. Global Dementia Drugs Market Share by Type in 2021 & 2028
    Figure 3. MAO Inhibitors Product Picture
    Figure 4. Cholinesterase Inhibitors Product Picture
    Figure 5. Glutamate Inhibitors Product Picture
    Figure 6. Global Dementia Drugs Market Share by Application in 2021 & 2028
    Figure 7. Hospital Pharmacies
    Figure 8. Retail Pharmacies
    Figure 9. Others
    Figure 10. Dementia Drugs Report Years Considered
    Figure 11. Global Dementia Drugs Sales 2017-2028 (K Units)
    Figure 12. Global Dementia Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Dementia Drugs Revenue 2017-2028 (US$ Million)
    Figure 14. Global Dementia Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 15. Global Dementia Drugs Sales Market Share by Region (2017-2022)
    Figure 16. Global Dementia Drugs Sales Market Share by Region (2023-2028)
    Figure 17. North America Dementia Drugs Sales YoY (2017-2028) & (K Units)
    Figure 18. North America Dementia Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Europe Dementia Drugs Sales YoY (2017-2028) & (K Units)
    Figure 20. Europe Dementia Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Asia-Pacific Dementia Drugs Sales YoY (2017-2028) & (K Units)
    Figure 22. Asia-Pacific Dementia Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Latin America Dementia Drugs Sales YoY (2017-2028) & (K Units)
    Figure 24. Latin America Dementia Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Middle East & Africa Dementia Drugs Sales YoY (2017-2028) & (K Units)
    Figure 26. Middle East & Africa Dementia Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. The Dementia Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 28. The Top 5 and 10 Largest Manufacturers of Dementia Drugs in the World: Market Share by Dementia Drugs Revenue in 2021
    Figure 29. Global Dementia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 30. Global Dementia Drugs Sales Market Share by Type (2017-2028)
    Figure 31. Global Dementia Drugs Revenue Market Share by Type (2017-2028)
    Figure 32. Global Dementia Drugs Sales Market Share by Application (2017-2028)
    Figure 33. Global Dementia Drugs Revenue Market Share by Application (2017-2028)
    Figure 34. North America Dementia Drugs Sales Market Share by Type (2017-2028)
    Figure 35. North America Dementia Drugs Revenue Market Share by Type (2017-2028)
    Figure 36. North America Dementia Drugs Sales Market Share by Application (2017-2028)
    Figure 37. North America Dementia Drugs Revenue Market Share by Application (2017-2028)
    Figure 38. North America Dementia Drugs Sales Share by Country (2017-2028)
    Figure 39. North America Dementia Drugs Revenue Share by Country (2017-2028)
    Figure 40. U.S. Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 41. Canada Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 42. Europe Dementia Drugs Sales Market Share by Type (2017-2028)
    Figure 43. Europe Dementia Drugs Revenue Market Share by Type (2017-2028)
    Figure 44. Europe Dementia Drugs Sales Market Share by Application (2017-2028)
    Figure 45. Europe Dementia Drugs Revenue Market Share by Application (2017-2028)
    Figure 46. Europe Dementia Drugs Sales Share by Country (2017-2028)
    Figure 47. Europe Dementia Drugs Revenue Share by Country (2017-2028)
    Figure 48. Germany Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 49. France Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 50. U.K. Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 51. Italy Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 52. Russia Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 53. Asia Pacific Dementia Drugs Sales Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Dementia Drugs Revenue Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Dementia Drugs Sales Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Dementia Drugs Revenue Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Dementia Drugs Sales Share by Region (2017-2028)
    Figure 58. Asia Pacific Dementia Drugs Revenue Share by Region (2017-2028)
    Figure 59. China Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 60. Japan Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 61. South Korea Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. India Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. Australia Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Taiwan Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Indonesia Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Thailand Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Malaysia Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 68. Philippines Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 69. Latin America Dementia Drugs Sales Market Share by Type (2017-2028)
    Figure 70. Latin America Dementia Drugs Revenue Market Share by Type (2017-2028)
    Figure 71. Latin America Dementia Drugs Sales Market Share by Application (2017-2028)
    Figure 72. Latin America Dementia Drugs Revenue Market Share by Application (2017-2028)
    Figure 73. Latin America Dementia Drugs Sales Share by Country (2017-2028)
    Figure 74. Latin America Dementia Drugs Revenue Share by Country (2017-2028)
    Figure 75. Mexico Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 76. Brazil Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 77. Argentina Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 78. Middle East and Africa Dementia Drugs Sales Market Share by Type (2017-2028)
    Figure 79. Middle East and Africa Dementia Drugs Revenue Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Dementia Drugs Sales Market Share by Application (2017-2028)
    Figure 81. Middle East and Africa Dementia Drugs Revenue Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Dementia Drugs Sales Share by Country (2017-2028)
    Figure 83. Middle East and Africa Dementia Drugs Revenue Share by Country (2017-2028)
    Figure 84. Turkey Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 85. Saudi Arabia Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 86. U.A.E Dementia Drugs Revenue (2017-2028) & (US$ Million)
    Figure 87. Dementia Drugs Value Chain
    Figure 88. Dementia Drugs Production Process
    Figure 89. Channels of Distribution
    Figure 90. Distributors Profiles
    Figure 91. Bottom-up and Top-down Approaches for This Report
    Figure 92. Data Triangulation
    Figure 93. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eisai, Inc
Janssen Pharmaceuticals, Inc
Biogen Pharmaceuticals
Forest Laboratories, Inc
Eli Lilly and Company
Novartis AG
Sanofi S.A
AstraZeneca GmbH
F. Hoffmann-La Roche
Merck & Co., Inc
Valeant Pharmaceutical International
Pfizer Inc
Teva Pharmaceuticals Industries
Frequently Asked Questions
Dementia Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Dementia Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Dementia Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports